Results 111 to 120 of about 1,570,153 (247)

Subjective outcome evaluation of a gifted education program: the Project GIFT in Hong Kong. [PDF]

BMC Psychol
Shek DTL, Cheung ACK, Hui ANN, Leung KH, Cheung RSH.   +4 more
europepmc   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

Molecular Oncology, Volume 20, Issue 6, Page 1513-1534, June 2026.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff, Manuela Moritz, Dennis Eggert, Anna Worthmann, Joerg Heeren, Henrike Zech, Till S. Clauditz, Waldemar Wilczak, Hartmut Schlüter, Christian S. Betz, Arne Böttcher, Jan Hahn   +11 more
wiley   +1 more source

Neurophysiological prediction of competitive orientation via EEG during outcome evaluation in gamified learning. [PDF]

NPJ Sci Learn
Watanabe H, Tabata A, Ishii C, Naruse Y.
europepmc   +1 more source

No harm, no foul: The outcome bias in ethical judgments [PDF]

We present six studies demonstrating that outcome information biases ethical judgments of others' ethically-questionable behaviors. In particular, we show that the same behaviors produce more ethical condemnation when they happen to produce bad rather ...
Don A. Moore, Max H. Bazerman, Francesca Gino   +2 more
core  

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, Volume 20, Issue 6, Page 1535-1555, June 2026.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Process and Outcome Evaluation of the National Institutes of Health Community Engagement Alliance. [PDF]

Public Health Rep
Chansky MC, Hood N, Price SM, Chen PM, Ferg R, Johnson LE, Carrington K, Stinson N, Zhang X, Mensah GA.   +9 more
europepmc   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, Volume 20, Issue 6, Page 1591-1611, June 2026.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

Process and outcome evaluation of a regional pulmonary embolism response team. [PDF]

Thromb J
Weekes AJ, Cerpa FC, Goonan KL, Polzella AL, Hogg MM, Cox D, Flannigan S, Cruz E, O'Neill HA, O'Connell NS, Troha DR.   +10 more
europepmc   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source

Health Care Use of Frail Older People: Follow-Up Outcome Evaluation of an Intensive Primary Care Programme at 24 and 36 Months. [PDF]

J Am Geriatr Soc
Palapar L, Cavadino A, Wignall J, Boyd ML, North D, Dawe M, McQueen J, Frey RA, Raphael DL, Kerse N.   +9 more
europepmc   +1 more source